Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome (ALPACS)

Viatris

Status and phase: Completed; Phase 4

Conditions: Acute Coronary Syndrome

Treatments: Drug: Atorvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00728988

A2581161

Details and patient eligibility

About

This present study is specifically designed to examine the efficacy and safety of a high pre-treatment dose of atorvastatin in Asian patients with NSTE-ACS in China and the Republic of Korea, by using a treatment paradigm similar to that employed in the ARMYDA-ACS study.

Enrollment: 499 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Non-ST elevated ACS; LDL-C > 80 mg/dl

Exclusion criteria

• ST elevated acute myocardial infarction; previously or currently treated with atorvastatin or other statins

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

499 participants in 2 patient groups

Atorvastatin Group

Experimental group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin

Usual Care Group

Other group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin